Weight Gain During Acute Treatment of an Initial Pulmonary Exacerbation is Associated with a Longer Interval to the Next Exacerbation in Adults with Cystic Fibrosis

Overview

Journal ERJ Open Res

Specialty Pulmonary Medicine

Date 2017 Aug 31

PMID 28852645

Authors

Helen L Barr

Miguel Camara

David Barrett

Paul Williams

Doug Forrester

Alan Smyth

David Honeybourne

Joanna Whitehouse

Edward Nash

Jane Dewar

Alan Knox

Andrew W Fogarty

Affiliations

Soon will be listed here.

Abstract

http://ow.ly/f1zl30dU9AO.

References

Forrester D, Knox A, Smyth A, Fogarty A . Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study. J Cyst Fibros. 2012; 12(3):284-9. PMC: 3655260. DOI: 10.1016/j.jcf.2012.08.008. View

Britto M, Kotagal U, Hornung R, Atherton H, Tsevat J, Wilmott R . Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest. 2002; 121(1):64-72. DOI: 10.1378/chest.121.1.64. View

Godfrey M, Oliver B . Accelerating the rate of improvement in cystic fibrosis care: contributions and insights of the learning and leadership collaborative. BMJ Qual Saf. 2014; 23 Suppl 1:i23-i32. DOI: 10.1136/bmjqs-2014-002804. View

Rosenfeld M, Emerson J, Pepe M, Smith A, Montgomery A, Ramsey B . Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr. 2001; 139(3):359-65. DOI: 10.1067/mpd.2001.117288. View

Barr H, Halliday N, Camara M, Barrett D, Williams P, Forrester D . Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis. Eur Respir J. 2015; 46(4):1046-54. PMC: 4589431. DOI: 10.1183/09031936.00225214. View

Heltshe S, Goss C, Thompson V, Sagel S, Sanders D, Marshall B . Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis. Thorax. 2015; 71(3):223-9. PMC: 4778725. DOI: 10.1136/thoraxjnl-2014-206750. View

Smyth A, Bell S, Bojcin S, Bryon M, Duff A, Flume P . European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J Cyst Fibros. 2014; 13 Suppl 1:S23-42. DOI: 10.1016/j.jcf.2014.03.010. View

Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A . Standardisation of spirometry. Eur Respir J. 2005; 26(2):319-38. DOI: 10.1183/09031936.05.00034805. View

Schechter M, Fink A, Homa K, Goss C . The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement. BMJ Qual Saf. 2014; 23 Suppl 1:i9-14. DOI: 10.1136/bmjqs-2013-002378. View

10.

Amadori A, Antonelli A, Balteri I, Schreiber A, Bugiani M, De Rose V . Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis. Respir Med. 2008; 103(3):407-13. DOI: 10.1016/j.rmed.2008.09.024. View

11.

Fogarty A, Britton J, Clayton A, Smyth A . Are measures of body habitus associated with mortality in cystic fibrosis?. Chest. 2012; 142(3):712-717. DOI: 10.1378/chest.11-2124. View

12.

Sanders D, Bittner R, Rosenfeld M, Redding G, Goss C . Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2010; 46(4):393-400. DOI: 10.1002/ppul.21374. View

13.

Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss C, Aitken M . Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med. 2002; 166(12 Pt 1):1550-5. DOI: 10.1164/rccm.200202-087OC. View

14.

Ratjen F, Doring G . Cystic fibrosis. Lancet. 2003; 361(9358):681-9. DOI: 10.1016/S0140-6736(03)12567-6. View

15.

Matel J . Nutritional management of cystic fibrosis. JPEN J Parenter Enteral Nutr. 2012; 36(1 Suppl):60S-7S. DOI: 10.1177/0148607111420156. View